Serum neuron-specific enolase (NSE) is associated with the overall survival of colorectal cancer: a retrospective study
PeerJ · 2024
DOI: 10.7717/peerj.18617 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2024. Verfasst von Junwei Peng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Phosphopyruvate Hydratase, Colorectal Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Research Program of Yunnan, First-Class Discipline Team of Kunming Medical University, Scientific Research Fund Project of Yunnan Provincial Department of Education.
Abstract (Originalsprache)
Background
Serum neuron-specific enolase (NSE) had been associated with survival of several cancers. However, its prognostic significance for colorectal cancer (CRC) has not been effectively discussed. We aimed to investigate the relationship between baseline serum NSE and the overall survival (OS) of colorectal adenocarcinoma (CRAD) patients.
Methods
A retrospective study had been conducted by including 564 histopathology confirmed CRAD patients between January 2013 and December 2018 from Yunnan Provincial Cancer hospital, China. Cox proportional hazards model was used to estimate the crude and adjusted associations between serum NSE measured at diagnosis and the OS of the patients. Restricted cubic spline (RCS) was further applied to delineate dose-response trend of the NSE-OS association.
Results
After controlling for possible confounding factors, baseline serum NSE was significantly associated with OS in CRAD: when dichotomizing by the median, patients with higher baseline serum NSE (NSE >= 12.93 ng/mL) were observed a worse prognosis (hazard ratio, HR: 1.82, 95% CI [1.30–2.55], p < 0.01). Stratified analysis by tumor stage revealed a stronger NSE-OS association in advanced CRAD patients. RCS disclosed a prominent dose-response relationship in NSE-OS association for all CRAD patients: along with the increase of baseline serum NSE, the adjusted HR of CRAD patients increased gradually. This dose-response trend is also evident in advanced stage CRAD patients, but not in early stage CRAD patients.
Conclusions
Serum NSE measured at diagnosis might be a useful prognostic indicator for CRAD, especially for advanced stage patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Kunming Medical University, Kunming, China.
- The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Förderung
- Basic Research Program of Yunnan
- First-Class Discipline Team of Kunming Medical University
- Scientific Research Fund Project of Yunnan Provincial Department of Education
Zitieren
APA
Peng, J., Ma, J., Lu, J., Ran, H., Yuan, Z., Zhou, H., Huang, Y., & Xiao, Y. (2024). Serum neuron-specific enolase (NSE) is associated with the overall survival of colorectal cancer: a retrospective study. PeerJ. https://doi.org/10.7717/peerj.18617
Vancouver
Peng J, Ma J, Lu J, Ran H, Yuan Z, Zhou H, et al. Serum neuron-specific enolase (NSE) is associated with the overall survival of colorectal cancer: a retrospective study. PeerJ. 2024. doi:10.7717/peerj.18617
BibTeX
@article{Peng2024,
author = {Peng, Junwei and Ma, Jie and Lu, Jian and Ran, Hailiang and Yuan, Zhongqin and Zhou, Hai and Huang, Yunchao and Xiao, Yuanyuan},
title = {Serum neuron-specific enolase (NSE) is associated with the overall survival of colorectal cancer: a retrospective study},
journal = {PeerJ},
year = {2024},
doi = {10.7717/peerj.18617}
}
EUVIMED